AI-generated price forecast for Ultragenyx Pharmaceutical Inc (RARE) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.
As of November 2026: K3vl4r's calibrated AI forecast currently reads RARE as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 16.72. Measured over its last 440 resolved daily forecasts (45-day window), the model's direction call on RARE was correct 76% of the time. See our public, auditable track record →
Last price
16.72
AI outlook
1/1 bullish
Timeframes up
1 / 1
Measured daily accuracy
76%
440 resolved forecasts · 45d window
| Horizon | Direction | Calibrated move (end of horizon) |
|---|---|---|
| 1-hour | — | — |
| 4-hour | — | — |
| Daily~4 weeks out | ▲ Up | +44.00% |
| Weekly | Not enough track record yet | — |
Calibrated: each horizon's forecast is weighted by how often the model has called RARE's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.
From the market-news feed the forecasts are read against.
🔒
See the full RARE forecast
Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.
Create a free account →Already have one? Log in
K3vl4r's calibrated AI forecast currently reads RARE as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Measured over its last 440 resolved daily forecasts (45-day window), the model's direction call on RARE was correct 76% of the time. Measured over its last 28 resolved weekly forecasts (60-day window), the model's direction call on RARE was correct 89% of the time. Accuracy is recomputed continuously against resolved outcomes and varies by symbol, horizon and market regime; past accuracy does not guarantee future results. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
K3vl4r's model projects RARE toward $23.93 over the next ~4 weeks, a +44.0% move from $16.62. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Part of Healthcare forecasts — browse the full sector.
Or see the full RARE price prediction (2027–2040), or the forecast for today, tomorrow and this week.
Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.
K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.
Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.